You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

ROCURONIUM BROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Rocuronium Bromide patents expire, and what generic alternatives are available?

Rocuronium Bromide is a drug marketed by Caplin, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Meitheal, Mylan Institutional, Piramal Critical, Prinston Inc, Sagent Pharms Inc, Sandoz, Tamarang, Teva Pharms, and West Ward Pharm Corp. and is included in fifteen NDAs.

The generic ingredient in ROCURONIUM BROMIDE is rocuronium bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rocuronium Bromide

A generic version of ROCURONIUM BROMIDE was approved as rocuronium bromide by HOSPIRA on November 26th, 2008.

  Try a Trial

Drug patent expirations by year for ROCURONIUM BROMIDE
Recent Clinical Trials for ROCURONIUM BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chosun University HospitalN/A
Assiut UniversityPhase 2/Phase 3
Yangzhou UniversityN/A

See all ROCURONIUM BROMIDE clinical trials

Pharmacology for ROCURONIUM BROMIDE

US Patents and Regulatory Information for ROCURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West Ward Pharm Corp ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 204679-001 Feb 28, 2017 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
West Ward Pharm Corp ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 204679-002 Feb 28, 2017 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Caplin ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 216234-001 Mar 2, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Prinston Inc ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 212668-001 May 26, 2022 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Tamarang ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 091115-001 Aug 27, 2012 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Gland Pharma Ltd ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 205656-001 Apr 4, 2018 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.